Infections during extracorporeal membrane oxygenation: epidemiology, risk factors, pathogenesis and prevention S Biffi, S Di Bella, V Scaravilli, AM Peri, G Grasselli, L Alagna, A Pesenti, ... International journal of antimicrobial agents 50 (1), 9-16, 2017 | 198 | 2017 |
Nosocomial infections during extracorporeal membrane oxygenation: incidence, etiology, and impact on patients’ outcome G Grasselli, V Scaravilli, S Di Bella, S Biffi, M Bombino, N Patroniti, L Bisi, ... Critical care medicine 45 (10), 1726-1733, 2017 | 131 | 2017 |
Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis E Righi, AM Peri, PNA Harris, AM Wailan, M Liborio, SW Lane, ... Journal of antimicrobial chemotherapy 72 (3), 668-677, 2017 | 109 | 2017 |
Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy S Sollima, L Milazzo, AM Peri, A Torre, S Antinori, M Galli Rheumatology 55 (11), 2084-2085, 2016 | 78 | 2016 |
Antimicrobial treatment challenges in the era of carbapenem resistance AM Peri, Y Doi, BA Potoski, PNA Harris, DL Paterson, E Righi Diagnostic microbiology and infectious disease 94 (4), 413-425, 2019 | 73 | 2019 |
Culture-independent detection systems for bloodstream infection AM Peri, PNA Harris, DL Paterson Clinical Microbiology and Infection 28 (2), 195-201, 2022 | 71 | 2022 |
TLR3 Mutations in Adult Patients With Herpes Simplex Virus and Varicella-Zoster Virus Encephalitis M Sironi, AM Peri, R Cagliani, D Forni, S Riva, M Biasin, M Clerici, A Gori The Journal of Infectious Diseases 215 (9), 1430-1434, 2017 | 66 | 2017 |
Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: a question needing an answer A Lombardi, L Alagna, G Bozzi, D Mangioni, A Muscatello, AM Peri, ... Journal of Hospital Infection 105 (3), 404-405, 2020 | 57 | 2020 |
Central nervous system nocardiosis in Queensland: a report of 20 cases and review of the literature N Rafiei, AM Peri, E Righi, P Harris, DL Paterson Medicine 95 (46), e5255, 2016 | 51 | 2016 |
Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study AM Peri, DP Bernasconi, N Galizzi, A Matteelli, L Codecasa, V Giorgio, ... BMC infectious diseases 18, 1-11, 2018 | 50 | 2018 |
Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study PNA Harris, AM Peri, AM Pelecanos, CM Hughes, DL Paterson, ... Antimicrobial Resistance & Infection Control 6, 1-8, 2017 | 39 | 2017 |
New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of care AM Peri, A Stewart, A Hume, A Irwin, PNA Harris Current Infectious Disease Reports 23 (8), 12, 2021 | 36 | 2021 |
Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014 L Milazzo, AM Peri, C Mazzali, R Grande, C Cazzani, D Ricaboni, ... Mycopathologia 178, 227-241, 2014 | 35 | 2014 |
Toward rapid sepsis diagnosis and patient stratification: what’s new from microbiology and omics science D Mangioni, AM Peri, GM Rossolini, B Viaggi, CF Perno, A Gori, ... The Journal of Infectious Diseases 221 (7), 1039-1047, 2020 | 24 | 2020 |
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1* 28 polymorphism carriers L Ferraris, O Vigano, A Peri, M Tarkowski, G Milani, S Bonora, F Adorni, ... Journal of Antimicrobial Chemotherapy 67 (9), 2236-2242, 2012 | 22 | 2012 |
Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and … AM Peri, W Ling, L Furuya-Kanamori, PNA Harris, DL Paterson BMC Infectious Diseases 22 (1), 794, 2022 | 18 | 2022 |
Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections AM Peri, MJ Bauer, H Bergh, D Butkiewicz, DL Paterson, PNA Harris Heliyon 8 (7), 2022 | 18 | 2022 |
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir L Milazzo, AM Peri, C Mazzali, C Magni, E Calvi, A De Nicolo, E Clementi, ... Journal of Antimicrobial Chemotherapy 70 (4), 1155-1160, 2015 | 15 | 2015 |
Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report AM Peri, L Bisi, A Cappelletti, E Colella, L Verga, C Borella, S Foresti, ... Clinical Microbiology and Infection 24 (7), 785-786, 2018 | 14 | 2018 |
Intestinal lymphangiectasia and reversible high liver stiffness L Milazzo, AM Peri, L Lodi, G Gubertini, AL Ridolfo, S Antinori Hepatology 60 (2), 759-761, 2014 | 12 | 2014 |